These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 11781357)

  • 21. Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation.
    Planavila A; Iglesias R; Giralt M; Villarroya F
    Cardiovasc Res; 2011 May; 90(2):276-84. PubMed ID: 21115502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of type 2 diabetic db/db mice with a novel PPARgamma agonist improves cardiac metabolism but not contractile function.
    Carley AN; Semeniuk LM; Shimoni Y; Aasum E; Larsen TS; Berger JP; Severson DL
    Am J Physiol Endocrinol Metab; 2004 Mar; 286(3):E449-55. PubMed ID: 14600074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor alpha associated with age-dependent cardiac toxicity.
    Watanabe K; Fujii H; Takahashi T; Kodama M; Aizawa Y; Ohta Y; Ono T; Hasegawa G; Naito M; Nakajima T; Kamijo Y; Gonzalez FJ; Aoyama T
    J Biol Chem; 2000 Jul; 275(29):22293-9. PubMed ID: 10801788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of c-myc in diabetic mice restores altered expression of the transcription factor genes that regulate liver metabolism.
    Riu E; Ferre T; Mas A; Hidalgo A; Franckhauser S; Bosch F
    Biochem J; 2002 Dec; 368(Pt 3):931-7. PubMed ID: 12230428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PPARalpha-mediated remodeling of repolarizing voltage-gated K+ (Kv) channels in a mouse model of metabolic cardiomyopathy.
    Marionneau C; Aimond F; Brunet S; Niwa N; Finck B; Kelly DP; Nerbonne JM
    J Mol Cell Cardiol; 2008 Jun; 44(6):1002-1015. PubMed ID: 18482733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteome changes in the myocardium of experimental chronic diabetes and hypertension: role of PPARα in the associated hypertrophy.
    Ares-Carrasco S; Picatoste B; Camafeita E; Carrasco-Navarro S; Zubiri I; Ortiz A; Egido J; López JA; Tuñón J; Lorenzo O
    J Proteomics; 2012 Mar; 75(6):1816-29. PubMed ID: 22234359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic impairment in response to early induction of C/EBPβ leads to compromised cardiac function during pathological hypertrophy.
    Banerjee D; Datta Chaudhuri R; Niyogi S; Roy Chowdhuri S; Poddar Sarkar M; Chatterjee R; Chakrabarti P; Sarkar S
    J Mol Cell Cardiol; 2020 Feb; 139():148-163. PubMed ID: 31958467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth.
    Barger PM; Brandt JM; Leone TC; Weinheimer CJ; Kelly DP
    J Clin Invest; 2000 Jun; 105(12):1723-30. PubMed ID: 10862787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of PPARalpha on cardiac glucose metabolism: a transcriptional equivalent of the glucose-fatty acid cycle?
    Finck BN
    Expert Rev Cardiovasc Ther; 2006 Mar; 4(2):161-71. PubMed ID: 16509812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.
    Zhang L; Jaswal JS; Ussher JR; Sankaralingam S; Wagg C; Zaugg M; Lopaschuk GD
    Circ Heart Fail; 2013 Sep; 6(5):1039-48. PubMed ID: 23861485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased contractile and metabolic reserve in peroxisome proliferator-activated receptor-alpha-null hearts can be rescued by increasing glucose transport and utilization.
    Luptak I; Balschi JA; Xing Y; Leone TC; Kelly DP; Tian R
    Circulation; 2005 Oct; 112(15):2339-46. PubMed ID: 16203912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy.
    Chiu HC; Kovacs A; Blanton RM; Han X; Courtois M; Weinheimer CJ; Yamada KA; Brunet S; Xu H; Nerbonne JM; Welch MJ; Fettig NM; Sharp TL; Sambandam N; Olson KM; Ory DS; Schaffer JE
    Circ Res; 2005 Feb; 96(2):225-33. PubMed ID: 15618539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac-specific overexpression of peroxisome proliferator-activated receptor-alpha causes insulin resistance in heart and liver.
    Park SY; Cho YR; Finck BN; Kim HJ; Higashimori T; Hong EG; Lee MK; Danton C; Deshmukh S; Cline GW; Wu JJ; Bennett AM; Rothermel B; Kalinowski A; Russell KS; Kim YB; Kelly DP; Kim JK
    Diabetes; 2005 Sep; 54(9):2514-24. PubMed ID: 16123338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor α.
    Liu F; Song R; Feng Y; Guo J; Chen Y; Zhang Y; Chen T; Wang Y; Huang Y; Li CY; Cao C; Zhang Y; Hu X; Xiao RP
    Circulation; 2015 Mar; 131(9):795-804. PubMed ID: 25637627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism.
    Gilde AJ; van der Lee KA; Willemsen PH; Chinetti G; van der Leij FR; van der Vusse GJ; Staels B; van Bilsen M
    Circ Res; 2003 Mar; 92(5):518-24. PubMed ID: 12600885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Restoration of glucose metabolism in leptin-resistant mouse hearts after acute myocardial infarction through the activation of survival kinase pathways.
    Witham W; Yester K; O'Donnell CP; McGaffin KR
    J Mol Cell Cardiol; 2012 Jul; 53(1):91-100. PubMed ID: 22507542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of PPAR-alpha activity in mice with cardiac-restricted expression of tumor necrosis factor: potential role of TGF-beta/Smad3.
    Sekiguchi K; Tian Q; Ishiyama M; Burchfield J; Gao F; Mann DL; Barger PM
    Am J Physiol Heart Circ Physiol; 2007 Mar; 292(3):H1443-51. PubMed ID: 17098824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A potential link between muscle peroxisome proliferator- activated receptor-alpha signaling and obesity-related diabetes.
    Finck BN; Bernal-Mizrachi C; Han DH; Coleman T; Sambandam N; LaRiviere LL; Holloszy JO; Semenkovich CF; Kelly DP
    Cell Metab; 2005 Feb; 1(2):133-44. PubMed ID: 16054054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.
    Dressel U; Allen TL; Pippal JB; Rohde PR; Lau P; Muscat GE
    Mol Endocrinol; 2003 Dec; 17(12):2477-93. PubMed ID: 14525954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Less extrahepatic induction of fatty acid beta-oxidation enzymes by PPAR alpha.
    Cook WS; Yeldandi AV; Rao MS; Hashimoto T; Reddy JK
    Biochem Biophys Res Commun; 2000 Nov; 278(1):250-7. PubMed ID: 11071880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.